• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Maternally administered vaccine reduces infant group B streptococcus infection

byDavid XiangandKiera Liblik
September 8, 2023
in Infectious Disease, Obstetrics, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial, a maternally administered vaccine for infant group B streptococcus (GBS) demonstrated a reduced risk of invasive GBS.

2. There was no significant difference in number of adverse events seen in patients who received the vaccine.

Evidence Rating Level: 1 (Excellent)

Study Rundown: GBS can cause sepsis and meningitis in newborns, with the primary risk factor being exposure to maternal rectovaginal group B streptococcal colonization during delivery. Often, pregnant women receive intrapartum antibiotic prophylaxis if they test positive for the GBS screen. Recently, a hexavalent CPS-cross-reactive material 197 glycoconjugate vaccine (GBS6) was developed as a maternal vaccine to prevent invasive GBS in infants. However, there is a gap in knowledge as to understanding the effectiveness of GBS6 and whether anti-CPS antibodies are transferred to newborn infants. Overall, this study found that GBS6 elicited anti-CPS antibodies against GBS in pregnant women, and transferred these antibodies to the infants at levels that are indicative of reduced risk for invasive GBS in newborn infants. This study was limited by not studying concurrent infections during pregnancy such as malaria or HIV, which can affect placental integrity and antibody transfer. Nevertheless, these study’s findings are significant, as they demonstrate that the GBS6 maternal vaccine for GBS may reduce the risk of infants developing invasive GBS disease.

Click here to read the study in NEJM

Relevant Reading: Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth

RELATED REPORTS

Evaluating scar outcomes in pediatric burn patients following skin grafting 

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

Second-line TAF-based ART improves viral suppression in pediatric HIV

In-Depth [randomized controlled trial]: This phase two placebo-controlled trial was conducted at three research centers in South Africa. Patients who were healthy pregnant women 18 to 40 years of age were eligible for the trial. Patients who did not provide informed consent were excluded from the trial. Eligible patients then received a single dose of 5 ÎĽg, 10 ÎĽg, or 20 ÎĽg per serotype of GBS6 with or without aluminum phosphate (AlPO4) or placebo. The primary outcome measured were anti-CPS IgG concentrations, which were determined using a quantitative direct immunoassay that measured antibody levels binding to CPS serotypes Ia, Ib, and II through V. Outcomes in the primary analysis were assessed via the Clopper and Pearson method with point estimates and exact 2-sided 95% confidence intervals. Based on the primary analysis, GBS6 induced effective maternal antibody responses, with maternal-to-infant antibody ratios of approximately 0.4 to 1.3. The percentage of infants with anti-CPS IgG concentrations above 0.184 ÎĽg per milliliter was 57 to 97% depending on vaccine formulation, which is the threshold determined to be associated with a 75% reduction in risk of disease. Overall, this study demonstrates that the GBS6 vaccine elicits anti-CPS antibodies against GBS in pregnant women that also subsequently transfer to infants at levels that would significantly reduce the risk of invasive GBS in the infants.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: group b streptococcusinfectious diseasematernal fetal medicineneonatologyobstetricspediatricspublic health
Previous Post

Spiritual health is associated with lower levels of burn-out in physicians

Next Post

Antibody NI006 for treatment of transthyretin amyloid cardiomyopathy caused no serious adverse events

RelatedReports

Pediatrics

Evaluating scar outcomes in pediatric burn patients following skin grafting 

June 26, 2025
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

June 9, 2025
Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Second-line TAF-based ART improves viral suppression in pediatric HIV

June 4, 2025
Sleep duration inversely related to childhood type 2 diabetes risk makers
Chronic Disease

Midlife weight loss is associated with decreased risk of mortality and chronic disease

June 3, 2025
Next Post
Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)

Antibody NI006 for treatment of transthyretin amyloid cardiomyopathy caused no serious adverse events

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Direct dispensation of free prenatal supplements improves outcomes in underserved communities

Patient Basics: Basal Cell Carcinoma

Comparison of surgical modalities in the treatment of Merkel Cell Carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation
  • Minimally invasive surgery is beneficial for epithelial ovarian cancer 
  • #VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.